GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Henlius Biotech Inc (HKSE:02696) » Definitions » Short-term investments

Shanghai Henlius Biotech (HKSE:02696) Short-term investments


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Henlius Biotech Short-term investments?

Short-term investments only applies to insurance companies.


Shanghai Henlius Biotech (HKSE:02696) Business Description

Traded in Other Exchanges
N/A
Address
No. 1801 Hongmei Road, 9th Floor, Innov Tower (Capitaland Building), Xuhui District, Shanghai, CHN, 200233
Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and innovative biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China and Overseas. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.